The FDA granted approval for PulmonX’s Zephyr endobronchial valve, used for treating breathing difficulties in patients with severe emphysema.

The device is placed in the lung airways of patients using a flexible bronchoscope during a hospital procedure.

The valves close during patient inhalation, keeping air from entering the damaged area of the lung and open during exhalation, releasing trapped air and relieving pressure.